A subsidiary of Poinsettia (300723.SZ) obtained a registration certificate for sertraline hydrochloride oral solution

Zhitong Finance App News, Yipinhong (300723.SZ) issued an announcement. Guangzhou Yipinhong Pharmaceutical Co., Ltd., a wholly-owned subsidiary of the company, recently received the “Drug Registration Certificate” for sertraline hydrochloride oral solution approved and issued by the State Drug Administration.

Sertraline is used to treat symptoms associated with depression, including depression accompanied by anxiety and with or without a history of mania. After satisfactory results, continuing to take sertraline can effectively prevent recurrence and recurrence of depression. Sertraline is also used to treat obsessive-compulsive disorder. After satisfactory results, continuing to take sertraline can effectively prevent the recurrence of the initial symptoms of obsessive-compulsive disorder. Sertraline hydrochloride is a selective serotonin reuptake inhibitor. Its mechanism of action is related to its inhibition of central neuronal serotonin reuptake.